Corteva shares slide after Brazil weakness prompts annual profit forecast cut

By Reuters News

- Corteva CTVA.N shares slid to their lowest in a year on Thursday after the US agrichemicals company slashed its annual profit forecast due to continued weakness in Brazilian markets.

The company expects full-year adjusted profit to be between 76 cents and 80 cents per share, compared with $3.60 to $3.80 forecast earlier.

  • Shares of Corteva, which makes crop protection solutions such as herbicides and fungicides, tumbled 22.8% to $9.36, and were on track to post their steepest percentage loss on record

  • Crop protection market conditions have become more challenging, particularly in Brazil, Corteva said

  • Farmer liquidity constraints, higher financing costs, just-in-time purchasing and increased pricing pressure resulted in a significantly softer market in Brazil than previously anticipated, the company said

  • Earlier this year, Corteva completed the separation of its seed and genetics business into a separate publicly traded company Vylor VYLR.N

  • "Corteva stumbled out of the gate in its first standalone earnings report," Oppenheimer analyst Kristen Owen said

  • Following the spinoff, "we expect Corteva's results to be more volatile due to the cyclicality of the crop protection market," Morningstar analyst Seth Goldstein said

  • Corteva expects 2026 adjusted operating earnings before interest, taxes, depreciation and amortization in the range of $1.1 billion to $1.125 billion

  • Analysts, on average, estimate EBITDA of $1.82 billion and adjusted profit of $1.63 per share for the year, according to data compiled by LSEG

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk